E-cigarette: Reexamining its Effectiveness and Regulation in Europe

Aug.14.2023
E-cigarette: Reexamining its Effectiveness and Regulation in Europe
E-cigarette sales are increasing, prompting calls for stricter regulations to curb the rising trend among teenagers in Europe.

The e-cigarette, once hailed as a smoking cessation tool, may warrant reconsideration as tobacco companies are now advocating for stricter regulations on its usage.


In recent years, the phenomenon of teenagers using e-cigarettes has been spreading across Europe.


Since 2013, the number of teenagers aged 11 to 17 in the UK who have used e-cigarettes has quadrupled. In France, over half of teenagers aged 17 have tried e-cigarettes. In Italy, the proportion of teenagers aged 11 to 17 who have used e-cigarettes in the past month has doubled since 2014, and there has also been a noticeable increase in Latvia and Romania.


While e-cigarettes are widely believed to assist adult smokers in quitting, government officials, doctors, public health experts, and the general public are now sounding the alarm over the increasing use of these products among teenagers. Even the industry itself is calling for stronger regulation.


James Murphy, director of research and science at British American Tobacco (BAT), has stated that the company is willing to take measures to reduce the appeal and accessibility of e-cigarettes to young people.


He stated:


I believe that if we establish these protective measures in our surroundings, it will further redirect the attention of adults who are interested in making a change, while making it less appealing for teenagers whom we do not want to be exposed to these products.


His comments echo those of his boss, Tadeu Marroco, the CEO of British American Tobacco, who earlier this month stated the need for "better regulations" to address the issue of youth vaping.


Since e-cigarettes first entered the market, there has been a significant shift with the emergence of small disposable e-cigarettes in soft colors and cotton candy-like flavors. These e-cigarettes are now easily obtainable from unscrupulous sellers across Europe.


A new reality has prompted people to question whether lawmakers were completely mistaken when they formulated regulations for e-cigarettes a decade ago, and if it is now necessary to amend these rules.


The intense showdown among the legislators, coupled with rumors, threats, and fierce lobbying.


On October 8, 2013, at the European Parliament in Strasbourg, tensions ran high as Linda McAvan, the chief negotiator for the Tobacco Products Directive, called for a "wise and calm" discussion, urging to avoid the "distortions" witnessed in recent weeks.


The topic of the meeting was the proposal by the European Commission to classify the majority of e-cigarettes as medicinal products, which would require them to go through a pharmaceutical authorization process. EU member states have mostly reached a consensus on this issue, but European Parliament members have not yet made a decision.


Lobbyists and avid e-cigarette users are becoming increasingly restless, fueling rumors that Brussels is planning to ban e-cigarettes. The members of parliament have been bombarded with intense lobbying tactics, with some describing the situation as unprecedented within the usual scope of parliamentary proceedings.


McCarthy, a member of the Labour Party in the UK, is also a member of the Social and Democratic Progressive Party. She stated that although the documents primarily address traditional cigarettes, the issue of e-cigarettes has quickly become a major topic of discussion.


It quickly turned into a highly aggressive lobbying campaign," the former Member of the European Parliament told Politico magazine. The CEO of an e-cigarette company was relentless, she said, leaving messages on her phone and sending emails to her, referring to McCawen as his "archenemy." She and her team had considered filing a police report.


In the end, lobbying groups and enthusiastic e-cigarette users successfully persuaded lawmakers that e-cigarettes require lenient regulatory measures.


They are nearly zealous advocates for e-cigarettes," liberal member of parliament Rebecca Taylor remarked to The New York Times, describing herself as "one of several European Parliament members who have been urged by former smokers to embrace the use of e-cigarettes.


Taylor and other members of liberal, European conservative, and European People's Party groups have proposed amendments that would eliminate the requirement for e-cigarettes to undergo medicinal authorization, only requiring authorization if they are claimed to be smoking cessation devices.


The amendment ultimately passed.


Dr. Jørgen Vestbo, a renowned clinical physician and honorary professor of respiratory medicine at the University Hospital of South Manchester in the United Kingdom, has been persistently critical of e-cigarettes. He firmly believes that transforming e-cigarettes into medical products could help prevent numerous issues that have already arisen.


Tidying up the chaos


The focus has shifted from health to attracting young people in the tobacco industry, and European regulations have generally worked well. Murphy describes it as a "fairly pragmatic regulatory framework" that has led many people to switch from smoking to e-cigarettes. He says,


This is why some of the lowest smoking rates in the world have emerged.


However, he also suggested that perhaps the rules should be adjusted to reduce the interest of teenagers in using e-cigarettes.


Murphy stated that BAT is willing to restrict the flavors of e-cigarettes to three categories, such as tobacco, mint, and fruit, while excluding candy and other novelty flavors like alcohol (which requires little effort for BAT as the company currently only offers these three flavor categories).


I believe that standards can be established regarding packaging and formatting, for example, 'these are the acceptable formats' and 'this is the permitted packaging style'.


The transformation has already begun.


The National Anti-Smoking Committee in France has proposed a ban on all flavors, while the then Health Minister, François Braun, expressed support for the prohibition of disposable e-cigarettes in May.


In Germany, the Bavarian government is pushing for a ban on disposable e-cigarettes across the European Union. The country's drug commissioner states that regulating the appearance and packaging of e-cigarettes will help reduce their usage among young people.


In the United Kingdom, the government is not only encouraging companies to seek drug licenses for their products, but it is also planning to introduce new taxes on e-cigarettes. Additionally, there are plans to offer introductory e-cigarette kits to smokers.


At the same time, the European Commission has retained the possibility of stricter e-cigarette regulation in its future revision of the Tobacco Products Directive, stating that further consideration should be given to the need for developing or clarifying regulations regarding the use of flavors and advertising promotions.


As Brussels starts considering the potential revision of regulations, lawmakers who supported the light-touch approach a decade ago now appear to be more open to regulation.


European People's Party MEP Peter Liese supported an amendment in 2013 to halt the categorization of medical products. He maintains an open stance towards implementing stricter regulations for e-cigarettes, including cracking down on the use of flavors.


He also pointed out that it is necessary to evaluate disposable e-cigarettes to determine whether they should continue to be allowed. He stated that the only reason these products exist is to attract those who are unwilling to purchase long-term use devices: "Of course, there is a hope for more children who want to quit smoking than smokers," he said.


Even e-cigarettes could potentially be included in prescriptions and could offer some help, as it would mean the product can be reimbursed, allowing individuals who truly need these products to access them at a lower price, according to Lisa.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12